Mirus Bio
Quincy Harenda has extensive experience in the field of technical product ownership and scientific support. With a background in medical microbiology and immunology, Quincy has worked in various roles at companies such as Mirus Bio and Immucor, Inc. Quincy's responsibilities have included laboratory management, formulation and optimization of product components, execution of study protocols, and continuous improvement projects. Quincy has also been involved in animal work, genotyping, flow cytometry, and data analysis. Currently pursuing further education at the University of Wisconsin-Milwaukee and University of Virginia Darden School of Business, Quincy is dedicated to expanding their knowledge and expertise in the field.
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.